{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:06Z","timestamp":1787022186584,"version":"build-2736575974"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction\/Aims<\/jats:title>\n                    <jats:p>\n                      Leprosy neuropathy (LN) may cause demyelination that worsens during the leprosy reactions (LR). Type-1 LR (T1LR) occurs in patients with cell-mediated immune response against\n                      <jats:italic>M. leprae,<\/jats:italic>\n                      and Type-2 LR (T2LR) occurs in multibacillary cases. The patterns of nerve impairment need to be clarified, as both demyelination and axonal degeneration are commonly observed. This study aimed to describe how to interpret the demyelinating impairment in LN.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective observational analysis of leprosy patients in a National Reference Center in Brazil between 2014\u20132023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>494 participants were included in this study. 3952 nerves were evaluated, with an average of 5.1 (\u00b15.4) nerves affected per patient. 23.5% (116\/494) of patients showed a demyelinating pattern defined by standard criteria, and 20.7% (24\/116) presented exclusively demyelinating abnormalities without evidence of secondary axonal loss. 81% (94\/116) presented conduction block, and 95.7% (111\/116) temporal dispersion, with both conditions concomitant in 76.7% (89\/116) of patients. 83.6% (97\/116) demonstrated prolonged distal motor latency, and 99.1% (115\/116) reduction in conduction velocity. 46.1% had T1LR and 17.9% T2LR. The comparison between patients with and without LR showed higher bacillary load, conduction block, and temporal dispersion in LR patients. 93.1% (108\/116) of patients fulfilled neurophysiological criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Among them, 46.3% presented clinical criteria for atypical CIDP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Leprosy is a spectral disease in which neural damage can manifest in different phenotypes. Demyelinating impairment is frequent and varies according to the clinical form and presence of LR. Although demyelinating impairment is common in the studied population, it does not reflect active disease. LN can also be misdiagnosed as other peripheral neuropathies, especially CIDP, in non-endemic areas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0343962","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:36:54Z","timestamp":1775669814000},"page":"e0343962","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?"],"prefix":"10.1371","volume":"21","author":[{"given":"Diogo Fernandes","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1213-9806","authenticated-orcid":true,"given":"Iago Resende","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Sabi\u00e3o","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique Sirotheau Corr\u00eaa","family":"Alves1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"de Oliveira Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Eul\u00e1lio","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Campos","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius Magno","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-3223","authenticated-orcid":true,"given":"Isabela Maria","family":"Bernardes Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"3","key":"pone.0343962.ref001","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/ijmy.ijmy_70_17","article-title":"Challenges beyond elimination in leprosy","volume":"6","author":"F Naaz","year":"2017","journal-title":"Int J Mycobacteriol"},{"issue":"4","key":"pone.0343962.ref002","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s13311-021-01153-z","article-title":"Treatment and Evaluation Advances in Leprosy Neuropathy","volume":"18","author":"GJ Ebenezer","year":"2021","journal-title":"Neurotherapeutics"},{"key":"pone.0343962.ref003","first-page":"119","article-title":"A classification of leprosy for research purposes","volume":"33","author":"DS Ridley","year":"1962","journal-title":"Lepr Rev"},{"issue":"2","key":"pone.0343962.ref004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-008-0917-3","article-title":"Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases","volume":"301","author":"LR Goulart","year":"2009","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"pone.0343962.ref005","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/brain\/awab396","article-title":"Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression","volume":"145","author":"PJ Tomaselli","year":"2022","journal-title":"Brain"},{"issue":"11","key":"pone.0343962.ref006","article-title":"Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects","volume":"11","author":"DFD Santos","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pone.0343962.ref007","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00415-003-1081-5","article-title":"Criteria for diagnosis of pure neural leprosy","volume":"250","author":"MR Jardim","year":"2003","journal-title":"J Neurol"},{"key":"pone.0343962.ref008","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1590\/0004-282X20130146","article-title":"Leprosy neuropathy: clinical presentations","volume":"71","author":"OJM Nascimento","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"pone.0343962.ref009","doi-asserted-by":"crossref","first-page":"117288","DOI":"10.1016\/j.jns.2020.117288","article-title":"Neuropathies of leprosy","volume":"420","author":"SV Khadilkar","year":"2021","journal-title":"J Neurol Sci"},{"key":"pone.0343962.ref010","doi-asserted-by":"crossref","first-page":"1304131","DOI":"10.3389\/fmed.2023.1304131","article-title":"Description of electroneuromiographic and laboratorial findings in leprosy neuropathy, according to its clinical forms: the confirmation of a spectral disease","volume":"10","author":"DF Dos Santos","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"pone.0343962.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000212","article-title":"Early diagnosis of neuropathy in leprosy--comparing diagnostic tests in a large prospective study (the INFIR cohort study)","volume":"2","author":"WH van Brakel","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pone.0343962.ref012","first-page":"62","article-title":"Reactions in leprosy","volume":"41","author":"WH Jopling","year":"1970","journal-title":"Lepr Rev"},{"issue":"11","key":"pone.0343962.ref013","article-title":"Immunopathogenesis of Type 1 and Type 2 Leprosy Reaction: An Update Review","volume":"15","author":"DAR Dewi","year":"2023","journal-title":"Cureus"},{"key":"pone.0343962.ref014","doi-asserted-by":"crossref","first-page":"841030","DOI":"10.3389\/fmed.2022.841030","article-title":"Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study","volume":"9","author":"DE Antunes","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"pone.0343962.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005396","article-title":"Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT\/CT-BR)","volume":"11","author":"EM Hungria","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pone.0343962.ref016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1489\/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2","article-title":"Epidemiological characteristics of leprosy reactions: 15 years experience from north India","volume":"72","author":"B Kumar","year":"2004","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"5","key":"pone.0343962.ref017","article-title":"Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts","volume":"12","author":"DFD Santos","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pone.0343962.ref018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.47276\/lr.81.3.206","article-title":"Neurophysiological patterns of ulnar nerve neuropathy in leprosy reactions","volume":"81","author":"JA Garbino","year":"2010","journal-title":"Lepr Rev"},{"key":"pone.0343962.ref019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clineuro.2015.01.008","article-title":"Leprosy neuropathy evaluated by NCS is independent of the patient\u2019s infectious state","volume":"131","author":"MR Jardim","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"pone.0343962.ref020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cnp.2021.02.003","article-title":"Comparison between nerve conduction study and high-resolution ultrasonography with color doppler in type 1 and type 2 leprosy reactions","volume":"6","author":"J Akita","year":"2021","journal-title":"Clin Neurophysiol Pract"},{"key":"pone.0343962.ref021","volume-title":"Diretrizes para vigil\u00e2ncia, aten\u00e7\u00e3o e elimina\u00e7\u00e3o da hansen\u00edase como problema de sa\u00fade p\u00fablica: manual t\u00e9cnico-operacional","author":"Brasil M da S, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis","year":"2016"},{"issue":"4","key":"pone.0343962.ref022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.47276\/lr.82.4.389","article-title":"Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection","volume":"82","author":"J Lobato","year":"2011","journal-title":"Lepr Rev"},{"issue":"11","key":"pone.0343962.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000328","article-title":"Enumeration of Mycobacterium leprae using real-time PCR","volume":"2","author":"RW Truman","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pone.0343962.ref024","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/cid\/ciw570","article-title":"Molecular Evidence for the Aerial Route of Infection of Mycobacterium leprae and the Role of Asymptomatic Carriers in the Persistence of Leprosy","volume":"63","author":"S Araujo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pone.0343962.ref025","volume-title":"Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations","author":"DC Preston","year":"2005","edition":"2"},{"issue":"3","key":"pone.0343962.ref026","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision","volume":"26","author":"PYK Van den Bergh","year":"2021","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"pone.0343962.ref027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0966-842X(99)01647-9","article-title":"How does Mycobacterium leprae target the peripheral nervous system?","volume":"8","author":"A Rambukkana","year":"2000","journal-title":"Trends in Microbiology"},{"issue":"1","key":"pone.0343962.ref028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1369-5274(00)00159-4","article-title":"Molecular basis for the peripheral nerve predilection of Mycobacterium leprae","volume":"4","author":"A Rambukkana","year":"2001","journal-title":"Curr Opin Microbiol"},{"issue":"5569","key":"pone.0343962.ref029","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1126\/science.1067631","article-title":"Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells","volume":"296","author":"A Rambukkana","year":"2002","journal-title":"Science"},{"issue":"4","key":"pone.0343962.ref030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.coi.2004.05.021","article-title":"Mycobacterium leprae-induced demyelination: a model for early nerve degeneration","volume":"16","author":"A Rambukkana","year":"2004","journal-title":"Curr Opin Immunol"},{"issue":"5586","key":"pone.0343962.ref031","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1126\/science.297.5586.1475c","article-title":"Mycobacterium leprae and demyelination","volume":"297","author":"THM Ottenhoff","year":"2002","journal-title":"Science"},{"issue":"1","key":"pone.0343962.ref032","doi-asserted-by":"crossref","first-page":"93","DOI":"10.47276\/lr.83.1.93","article-title":"Leprotic neuropathy misdiagnosed as chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"SH Kim","year":"2012","journal-title":"Lepr Rev"},{"issue":"3","key":"pone.0343962.ref033","article-title":"Report of a Leprosy case in Singapore: an age-old disease not to be forgotten in developed countries with low-prevalence settings","volume":"1","author":"YE Tan","year":"2019","journal-title":"Access Microbiol"},{"issue":"8","key":"pone.0343962.ref034","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3201\/eid2908.220367","article-title":"Case report of leprosy in central Florida, USA, 2022","volume":"29","author":"A Bhukhan","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pone.0343962.ref035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3201\/eid2401.170547","article-title":"Leprosy in nonimmigrant Canadian man without travel outside North America, 2014","volume":"24","author":"PE Bonnar","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"pone.0343962.ref036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010799","article-title":"Diagnosing and treating leprosy in a non-endemic setting in a national centre, London, United Kingdom 1995-2018","volume":"16","author":"DN Lockwood","year":"2022","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:36:59Z","timestamp":1775669819000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343962"}},"subtitle":[],"editor":[{"given":"Divakar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343962","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}